VAL.L
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL301, a peptide ingredient that in pre-clinical development for the treatment of women with endometriosis; and BC201, a combination of the pep...[Read more]
Industry
Biotechnology
IPO Date
2002-01-07
Stock Exchange
LSE
Ticker
VAL.L
According to ValiRx plc’s latest financial reports and current stock price. The company's current Enterprise Value is 760.65K. This represents a change of -62.87% compared to the average of 2.05M of the last 4 quarters.
The mean historical Enterprise Value of ValiRx plc over the last ten years is 4.42M. The current 760.65K Enterprise Value has changed 1.62% with respect to the historical average. Over the past ten years (40 quarters), VAL.L's Enterprise Value was at its highest in in the December 2021 quarter at 23.05M. The Enterprise Value was at its lowest in in the June 2011 quarter at -2272604.18.
Average
4.42M
Median
482.93K
Minimum
-522872.81
Maximum
23.03M
Discovering the peaks and valleys of ValiRx plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.60%
Maximum Annual Enterprise Value = 23.03M
Minimum Annual Increase = -820.06%
Minimum Annual Enterprise Value = -522872.81
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | -522872.81 | -108.95% |
| 2023 | 5.84M | -39.93% |
| 2022 | 9.72M | -57.78% |
| 2021 | 23.03M | 310.19% |
| 2020 | 5.61M | 2.60% |
| 2019 | 208.08K | -820.06% |
| 2018 | -28897.76 | -88.94% |
| 2017 | -261376.14 | -134.49% |
| 2016 | 757.79K | -533.99% |
| 2015 | -174608.11 | -61.40% |
The current Enterprise Value of ValiRx plc (VAL.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.01M
5-year avg
8.74M
10-year avg
4.42M
ValiRx plc’s Enterprise Value is greater than Physiomics Plc (342.26K), less than Genedrive Plc (3.81M), greater than Trellus Health plc (-380286.07), less than Roquefort Therapeutics plc (2.40M), less than Theracryf Plc (2.40M), less than CRISM Therapeutics Corporation (4.20M), greater than Futura Medical plc (-272277.00), less than Cizzle Biotechnology Holdings Plc (6.31M), greater than Feedback plc (-2510297.00), less than Nuformix plc (5.49M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 342.26K | N/A | |
| 3.81M | N/A | |
| -380286.07 | N/A | |
| 2.40M | N/A | |
| 2.40M | N/A | |
| 4.20M | N/A | |
| -272277.00 | N/A | |
| 6.31M | N/A | |
| -2510297.00 | N/A | |
| 5.49M | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ValiRx plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ValiRx plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ValiRx plc's Enterprise Value?
What is the highest Enterprise Value for ValiRx plc (VAL.L)?
What is the 3-year average Enterprise Value for ValiRx plc (VAL.L)?
What is the 5-year average Enterprise Value for ValiRx plc (VAL.L)?
How does the current Enterprise Value for ValiRx plc (VAL.L) compare to its historical average?